SRPT selling $287.5M* of stock on unspecified terms: https://finance.yahoo.com/news/sarepta-therapeutics-announces-proposed-250-110000295.html The CEO is buying $2M of the offering at the (yet unknown) public price. *Assuming exercise of underwriter’s option.